Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 265-274
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.265
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.265
Table 1 Clinicopathologic characteristics of 52 patients undergoing total pancreatectomy
Variable | No. of patients |
Mean age ± SD (yr) | 60.3 ± 9.0 |
Sex (male) | 32 |
Pathology | |
Adenocarcinoma | 43 |
Cystadenocarcinoma | 2 |
Invasive IPMN | 4 |
Acinar adenocarcinoma | 1 |
Adenosquamous carcinoma | 1 |
Renal cell carcinoma metastasis | 1 |
Tumor location | |
Head | 28 |
Corpus | 15 |
Tail | 3 |
> 1 location | 6 |
Median primary tumor size (IQR) (cm) | 4.7 (3.0-6.0) |
Venous invasion | 26 |
Lymph node invasion | 18 |
Splenectomy | 11 |
Operative time (IQR) (min) | 472.5 (421.3-548.8) |
Operative arrangement | |
Planned | 20 |
Unplanned | 32 |
Postoperative complication1 | |
Gastroplegia | 4 |
Gastrointestinal or abdominal hemorrhage bleeding | 1 |
Pneumonia | 14 |
Abdominal infection | 9 |
Hepatic failure | 1 |
Respiratory failure | 1 |
Length of postoperative hospital stay (IQR) (d) | 12.0 (10.0-17.8) |
Neoadjuvant treatment | 14 |
Adjuvant treatment | 52 |
Median recurrence-free time (IQR) (mo) | 4.7 (2.7-13.6) |
Median survival time (IQR) (mo) | 20.9 (10.2-51.0) |
1-year survival (%) | 63.4 |
3-year survival (%) | 24.2 |
5-year survival (%) | 12.5 |
- Citation: Shi HJ, Jin C, Fu DL. Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy. World J Gastroenterol 2017; 23(2): 265-274
- URL: https://www.wjgnet.com/1007-9327/full/v23/i2/265.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i2.265